SURGICAL-TREATMENT AND REGIONAL CHEMOTHERAPY IN MELANOMA OF THE EXTREMITIES

被引:0
作者
HENNEKING, K [1 ]
BINDER, J [1 ]
WEYERS, W [1 ]
SCHWEMMLE, K [1 ]
机构
[1] UNIV GIESSEN,HAUTKLIN,W-6300 GIESSEN,GERMANY
来源
CHIRURG | 1993年 / 64卷 / 02期
关键词
EXTREMITY MELANOMA; SURGICAL TREATMENT; ISOLATED LIMB PERFUSION; ELECTIVE LYMPH NODE DISSECTION; PROGNOSTIC FACTORS;
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
Since 1979, our treatment protocol for extremity melanoma includes wide local excision, regional lymph node dissection and hyperthermic limb perfusion. We report on the results of a follow-up of the patients treated in the first decade (n = 451). According to the UICC Classification of 1987, 4% of our patients were in stage I, 36% in stage II, 50% in stage III und 9% in stage IV The respective 5-year survival rates were 93%, 91%, 49%, and 20%. We conclude that regional chemotherapy appears to be beneficial even for stage II patients, as 5-year survival rates of more than 90% can be achieved.
引用
收藏
页码:134 / 138
页数:5
相关论文
共 17 条
[1]   MALIGNANT-MELANOMA - A UNIFYING CONCEPT [J].
ACKERMAN, AB .
HUMAN PATHOLOGY, 1980, 11 (06) :591-595
[2]  
AIGNER K, 1983, LANGENBECK ARCH CHIR, V359, P113
[3]   THERAPY OF MALIGNANT-MELANOMA [J].
BALCH, CM .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1985, 110 (46) :1786-1791
[4]  
BALCH CM, 1985, CUTANEOUS MELANOMA
[6]  
CLARK WH, 1969, CANCER RES, V29, P705
[7]  
EDWARDS MJ, 1990, ARCH SURG-CHICAGO, V125, P317
[8]   TO PERFUSE OR NOT TO PERFUSE - A RETROSPECTIVE COMPARATIVE-STUDY TO EVALUATE THE EFFECT OF ADJUVANT ISOLATED REGIONAL PERFUSION IN PATIENTS WITH STAGE-I EXTREMITY MELANOMA WITH A THICKNESS OF 1.5 MM OR GREATER [J].
FRANKLIN, HR ;
KOOPS, HS ;
OLDHOFF, J ;
CZARNETZKI, BM ;
MACHER, E ;
KROON, BBR ;
WELVAART, K ;
VANDERVELDEN, JW ;
VANDIJK, E ;
VANDERESCH, EP ;
OOSTERHUIS, JW ;
HUISMAN, SJ ;
HART, AAM ;
RUMKE, P .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (04) :701-708
[9]  
GHUSSEN F, 1988, CANCER-AM CANCER SOC, V61, P654, DOI 10.1002/1097-0142(19880215)61:4<654::AID-CNCR2820610406>3.0.CO
[10]  
2-V